Yonghe Medical Group Co., Ltd. (HKG:2279)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.135
-0.050 (-2.29%)
Sep 2, 2026, 3:42 PM HKT

Yonghe Medical Group Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
121.3273.71-226.34-546.39-85.86120.19
Depreciation & Amortization
229.47239.2312.75333.57220.22199.8
Other Amortization
4.484.482.461.274.461.17
Loss (Gain) From Sale of Assets
4.134.1342.2345.9-0.091.13
Asset Writedown & Restructuring Costs
1.421.4260.8328.13--
Loss (Gain) From Sale of Investments
3.193.19-0.320.260.14-0.15
Stock-Based Compensation
0.060.060.110.180.180.18
Other Operating Activities
81.9864.6116.7519.87-122.7138.12
Change in Accounts Receivable
3.43.435.320.15-1.94-8.21
Change in Inventory
14.7214.7226.4812.08-34.95-26.12
Change in Accounts Payable
13.113.1-44.260.46-53.4742.3
Change in Unearned Revenue
69.6969.697.727.38-34.5568.88
Change in Other Net Operating Assets
3.823.82-5.15---
Operating Cash Flow
550.78495.53228.62-17.15-108.56437.28
Operating Cash Flow Growth
51.68%116.75%----12.82%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-23.8-17.77-45.66-159.19-240.57-181.63
Sale of Property, Plant & Equipment
0.280.280.873.031.790.5
Cash Acquisitions
---0.37-1.6--3.8
Divestitures
---7.5--
Sale (Purchase) of Intangibles
-0.4-1.13-8.1-12.12-2.94-9.01
Investment in Securities
-50-50-398.25-408.84-
Other Investing Activities
-89.19--9.71--
Investing Cash Flow
-163.11-68.61-53.26245.58-650.57-193.94

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-579.81154.5475.47232.69
Total Debt Issued
5579.81154.5475.47232.69
Short-Term Debt Repaid
--55-182.55-1.8-149.64-184.85
Long-Term Debt Repaid
--164.83-182.2-239.1-194.66-204.74
Total Debt Repaid
-219.83-219.83-364.75-240.9-344.3-389.6
Net Debt Issued (Repaid)
-214.83-214.83-284.94-86.37-268.84-156.91
Issuance of Common Stock
----91.881,381
Repurchase of Common Stock
-0.09-0.09-1.94-96.5-79.04-
Common Dividends Paid
-----43.16-69.8
Other Financing Activities
14.87-0.64-3.84-2.34-33.89-125.8
Financing Cash Flow
-200.05-215.56-290.72-185.2-333.051,028

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.2-0.2-0.01-5.191.081.78
Net Cash Flow
187.35211.15-115.3738.12-1,0011,273

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
526.97477.76182.95-176.35-349.14255.65
Free Cash Flow Growth
62.79%161.14%----28.86%
Free Cash Flow Margin
27.34%26.42%10.14%-9.92%-24.71%11.79%
Free Cash Flow Per Share
1.050.950.36-0.35-0.680.59
Levered Free Cash Flow
404.29404152.07-53.08-314.18226.97
Unlevered Free Cash Flow
417.71418.4177.83-19.23-282.16259.43

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.640.643.842.341.613.95
Cash Income Tax Paid
2.732.734.475.558.11103.92
Change in Working Capital
104.72104.7220.15100.07-124.9176.85